First Republic Investment Management, Inc. Vyant Bio, Inc. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.99 - $1.61 $40,598 - $66,024
-41,009 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.88 - $4.81 $118,105 - $197,253
41,009 New
41,009 $153,000

Others Institutions Holding VYNT

# of Institutions
2
Shares Held
213K
Call Options Held
0
Put Options Held
0
View Full List

About Vyant Bio, Inc.

VYNT Quotes by TradingView
  • Ticker VYNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,343,200
  • Description
  • Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...
More about VYNT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email